Choueiri et al. reported that out of 10 Xp11.2 RCC patients, 3 had positive PD-L1 expression in tumor cells and 9 harbored PD-L1-positive tumor infiltrating immune cells23. The gene discussed is CD274; the disease is neoplasm.